anticardiolipin antibodies

an·ti·car·di·o·lipin an·ti·bod·ies

antibodies directed against cardiolipid, a phosphorylated polysaccharide ester of fatty acids found in cell membranes. Associated with immune-mediated illnesses, syphilis, and strokes; thought to be from a hypercoagulable state.

anticardiolipin antibodies

See ANTIPHOSPHOLIPID SYNDROME.
References in periodicals archive ?
Similarly, rheumatoid factor, anti-nuclear antibodies, anticardiolipin antibodies, antineutrophil cytoplasmic antibodies, anti-DNA antibodies and anti-Brucella antibodies were not investigated in the absence of indicative clinical signs in our patient.
Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages.
International Society of Thrombosis and Haemostasis (ISTH) guidelines were followed to test Anticardiolipin antibodies, beta-2 glycoprotein I antibodies and lupus anticoagulant.10
A thrombophilia screen, including anticardiolipin antibodies, proteins S and C, activated protein C resistance, antithrombin III, and erythrocyte sedimentation rate, was normal.
The disease is defined by a combination of at least one clinical feature characterized by vascular thrombosis or pregnancy morbidity and elevated titers of antiphospholipid antibodies (aPL), which include anti-Beta2 Glycoprotein-I antibodies, anticardiolipin antibodies, and lupus anticoagulant (3).
Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
SAN DIEGO -- While use of the investigational agent blisibimod did not meet the primary endpoint in a phase 3 trial in systemic lupus erythematosus (SLE), it was associated with steroid sparing, decreased urine protein, a trend toward decreased anti-double-stranded DNA antibodies, and significant decreases in anticardiolipin antibodies and immunoglobulin levels.
Antiphospholipid antibody syndrome (APS) is a multisystem autoimmune disorder characterized by vascular thromboses and/or pregnancy loss associated with persistently positive antiphospholipid antibodies (aPL) indicated by lupus anticoagulant (LA) test, anticardiolipin antibodies (aCL), and/or anti-beta2 glycoprotein-I antibody (aB2GPI) [1].
0.1-0.4), c-ANCA, p-ANCA, antiphospholipids including anticardiolipin antibodies, IgG less than 8.0 GP (Ref.
Undetectable anticardiolipin antibodies, which are the most sensitive in diagnosing antiphospholipid syndrome [4], allow reasonably excluding this cause of adrenal failure.
The lupus anticoagulant assay was consistently negative, and anticardiolipin antibodies were not detected throughout the clinical course.
Clinical Criteria Clinical and Laboratory Events Thrombosis Venous, arterial, or small vessel [greater than or equal to] 2 unexplained fetal losses(<10 weeks of gestation) Pregnancy [greater than or equal to] 1 morbidity unexplained fetal losses (>10 weeks of gestation) [greater than or equal to] 1 premature births of morphologically normal neonates at or before 34th week of gestation Anticardiolipin antibodies Laboratory IgG or IgM present in > 40 GPL criteria or MPL on two occasions at least 12 weeks apart Anti-b2GPl of IgG/IgM > 99th percentile